Keywords: ogs, signs, alzheimer, deal, pfizer, oxford, glycosciences

OGS Signs Alzheimer's Deal With Pfizer

Article | 07 April 1998

Print This

Oxford GlycoSciences of the UK has entered into a research collaborationwith US giant Pfizer, using its proteomics technology to identify ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in